Litcius/Paper detail

High Systemic Immune-Inflammation Index (SII) Represents an Unfavorable Prognostic Factor for Small Cell Lung Cancer Treated with Etoposide and Platinum-Based Chemotherapy

Chunyan Wang, Jin Shi, Shanqi Xu, Shoubo Cao

2020Lung43 citationsDOI

Topics & Concepts

MedicineEtoposideInternal medicineChemotherapyUnivariate analysisLung cancerOncologyRadiation therapyMultivariate analysisGastroenterologyLactate dehydrogenaseStage (stratigraphy)CancerMetastasisChemistryBiochemistryEnzymePaleontologyBiologyInflammatory Biomarkers in Disease PrognosisLung Cancer Research StudiesCancer Immunotherapy and Biomarkers
High Systemic Immune-Inflammation Index (SII) Represents an Unfavorable Prognostic Factor for Small Cell Lung Cancer Treated with Etoposide and Platinum-Based Chemotherapy | Litcius